Skip to main content

Current role of LC–MS(/MS) in doping control

Analytical and Bioanalytical Chemistry volume 388, pages 1351–1358 (2007)Cite this article

Abstract

Liquid chromatography–(tandem) mass spectrometry (LC–MS/MS) has revolutionized the detection assays used in doping control analysis over the last decade. New methods have enabled the determination of drugs that were formerly difficult to detect or undetectable at preceding sample concentrations, and complex and/or time-consuming procedures based on alternative chromatographic–mass spectrometric or immunochemical principles have been replaced by faster, more comprehensive and robust assays. A critical overview of the contributions of LC–MS(/MS) to sports drug testing is provided, including recent developments regarding low and high molecular weight drugs.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Maurer HH (2004) Clin Chem Lab Med 42:1310–1324

    Article  CAS  Google Scholar 

  2. Maurer HH, Peters FT (2005) Ther Drug Monit 27:686–688

    Article  CAS  Google Scholar 

  3. Politi L, Groppi A, Polettini A (2005) J Anal Toxicol 29:1–14

    CAS  Google Scholar 

  4. Thevis M, Schänzer W (2005) Curr Org Chem 9:825–848

    Article  CAS  Google Scholar 

  5. Thevis M, Schänzer W (2007) Mass Spectrom Rev 26:79–107

    Article  CAS  Google Scholar 

  6. Thevis M, Schänzer W (2005) Curr Proteomics 2:191–208

    Article  CAS  Google Scholar 

  7. World Anti-Doping Agency (2005) The 2006 prohibited list: international standard. World Anti-Doping Agency, Montreal, Canada. Accessed January 22, 2007. http://www.wada-ama.org/rtecontent/document/2006_LIST.pdf

  8. Thevis M, Schänzer W (2005) J Am Soc Mass Spectrom 16:1660–1669

    Article  CAS  Google Scholar 

  9. Thevis M, Opfermann G, Bommerich U, Schänzer W (2004) J Mass Spectrom 40:494–502

    Article  CAS  Google Scholar 

  10. Deventer K, Eenoo PV, Delbeke FT (2006) Biomed Chromatogr 20:429–433

    Article  CAS  Google Scholar 

  11. Leinonen A, Kuuranne T, Kotiaho T, Kostiainen R (2004) Steroids 69:101–109

    Article  CAS  Google Scholar 

  12. Mazzarino M, Botre F (2006) Rapid Comm Mass Spectrom 20:3465–3476

    Article  CAS  Google Scholar 

  13. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang Y-C, Hatton CK (2004) Rapid Commun Mass Spectrom 18:1245–1249

    Article  CAS  Google Scholar 

  14. Thevis M, Geyer H, Mareck U, Schänzer W (2005) J Mass Spectrom 40:955–962

    Article  CAS  Google Scholar 

  15. Nielen MW, Bovee TF, van Engelen MC, Rutgers P, Hamers AR, van Rhijn JH, Hoogenboom LR (2006) Anal Chem 78:424–431

    Article  CAS  Google Scholar 

  16. Chen F, Rodan GA, Schmidt A (2002) Zhonghua Nan Ke Xue 8:162–168

    CAS  Google Scholar 

  17. Chen J, Kim J, Dalton JT (2005) Mol Interv 5:173–188

    Article  CAS  Google Scholar 

  18. Mohler ML, Nair VA, Hwang DJ, Rakov IM, Patil R, Miller DD (2005) Exp Opin Ther Patents 15:1565–1585

    Article  CAS  Google Scholar 

  19. Thevis M, Kamber M, Schänzer W (2006) Rapid Commun Mass Spectrom 20:870–876

    Article  CAS  Google Scholar 

  20. Schänzer W, Geyer H, Fusshöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M (2006) Rapid Comm Mass Spectrom 20:2252–2258

    Article  CAS  Google Scholar 

  21. Thevis M, Schebalkin T, Thomas A, Schänzer W (2005) Chromatographia 62:435–439

    Article  CAS  Google Scholar 

  22. Thevis M, Fußhöller G, Geyer H, Mareck U, Sigmund G, Koch A, Thomas A, Schänzer W (2006) Chromatographia 64:441–446

    Article  CAS  Google Scholar 

  23. Donike M (1970) Sportarzt und Sportmedizin 21:27–30

    Google Scholar 

  24. Donike M, Jaenicke L, Stratmann D, Hollmann W (1970) J Chromatogr 52:237–250

    Article  CAS  Google Scholar 

  25. Hemmersbach P, de la Torre R (1996) J Chromatogr B 687:221–238

    Article  CAS  Google Scholar 

  26. Maurer HH (1992) J Chromatogr 580:3–41

    Article  CAS  Google Scholar 

  27. Donike M, Derenbach J (1976) Z Anal Chem 279:128–129

    Article  CAS  Google Scholar 

  28. Deventer K, Van Eenoo P, Delbeke FT (2006) Rapid Commun Mass Spectrom 20:877–882

    Article  CAS  Google Scholar 

  29. Apollonio LG, Pianca DJ, Whittall IR, Maher WA, Kyd JM (2006) J Chromatogr B 836:111–115

    Article  CAS  Google Scholar 

  30. Shpak AV, Appolonova SA, Semenov VA (2005) J Chromatogr Sci 43:11–21

    CAS  Google Scholar 

  31. Thevis M, Sigmund G, Schiffer AK, Schänzer W (2006) Eur J Mass Spectrom 12:129–136

    Article  CAS  Google Scholar 

  32. Thevis M, Schänzer W (2005) J Chromatogr Sci 43:22–31

    CAS  Google Scholar 

  33. Thevis M, Opfermann G, Schänzer W (2004) Eur J Mass Spectrom 10:673–681

    Article  CAS  Google Scholar 

  34. Gasthuys M, Alves S, Fenaille F, Tabet JC (2004) Anal Chem 76:6628–6634

    Article  CAS  Google Scholar 

  35. Gasthuys M, Alves S, Tabet J (2005) Anal Chem 77:3372–3378

    Article  CAS  Google Scholar 

  36. Goebel C, Alma C, Howe C, Kazlauskas R, Trout G (2005) J Chromatogr Sci 43:39–46

    CAS  Google Scholar 

  37. Thevis M, Ogorzalek Loo RR, Loo JA, Schänzer W (2003) Anal Chem 75:3287–3293

    Article  CAS  Google Scholar 

  38. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W (2005) Anal Chem 77:3579–3585

    Article  CAS  Google Scholar 

  39. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W (2006) Anal Chem 78:1897–1903

    Article  CAS  Google Scholar 

  40. Gam LH, Tham SY, Latiff A (2003) J Chromatogr B 792:187–196

    Article  CAS  Google Scholar 

  41. Thevis M, Bredehöft M, Geyer H, Kamber M, Delahaut P, Schänzer W (2006) Rapid Commun Mass Spectrom 20:3551–3556

    Article  CAS  Google Scholar 

  42. Schumacher YO, Ashenden M (2004) Sports Med 34:141–150

    Article  Google Scholar 

  43. Schumacher YO, Schmid A, Dinkelmann S, Berg A, Northoff H (2001) Int J Sports Med 22:566–571

    Article  CAS  Google Scholar 

  44. Sonksen PH (2001) J Endocrinol 170:13–25

    Article  CAS  Google Scholar 

  45. Wolfe RR (2005) Curr Opin Clin Nutr Metab Care 8:61–65

    Article  CAS  Google Scholar 

  46. Wolfe RR (2000) Curr Opin Clin Nutr Metab Care 3:67–71

    Article  CAS  Google Scholar 

  47. World Anti-Doping Agency (2004) WADA technical document TD2003IDCR. World Anti-Doping Agency, Montreal, Canada. Accessed January 22, 2007. http://www.wada-ama.org/rtecontent/document/criteria_1_2.pdf

  48. Commission of the European Communities (2002) Commission decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Commission of the European Communities, Brussels, Belgium. Accessed January 22, 2007. http://eur-lex.europa.eu/LexUriServ/site/en/oj/2002/l_221/l_22120020817en00080036.pdf

  49. US Department of Health and Human Services—Food and Drug Administration (2003) Guidance for industry: Mass spectrometry for confirmation of the identity of animal drug residues: final guidance. FDA, Washington, DC. Accessed January 22, 2007. http://www.fda.gov/cvm/Guidance/guide118.pdf#search=%22FDA%20mass%20spectrometry%20%22

  50. Van Eenoo P, Delbeke FT (2004) Chromatographia 59:S39–S44

    Article  CAS  Google Scholar 

  51. Stein SE, Heller DN (2006) J Am Soc Mass Spectrom 17:823–835

    Article  CAS  Google Scholar 

  52. Mann M, Wilm M (1994) Anal Chem 66:4390–4399

    Article  CAS  Google Scholar 

  53. Zhang Z, Sun S, Zhu X, Chang S, Liu X, Yu C, Bu D, Chen R (2006) BMC Bioinformatics 7:222

    Article  CAS  Google Scholar 

  54. Eng JK, Mccormack AL, Yates JR (1994) J Am Soc Mass Spectrom 5:976–989

    Article  CAS  Google Scholar 

  55. Yates JR 3rd (1998) Electrophoresis 19:893–900

    Article  CAS  Google Scholar 

  56. Bethem R, Boison J, Gale J, Heller D, Lehotay S, Loo J, Musser S, Price P, Stein S (2003) J Am Soc Mass Spectrom 14:528–541

    Article  CAS  Google Scholar 

  57. Wu CC, MacCoss MJ (2002) Curr Opin Mol Ther 4:242–250

    CAS  Google Scholar 

  58. Aebersold R, Mann M (2003) Nature 422:198–207

    Article  CAS  Google Scholar 

  59. Ferguson PL, Smith RD (2003) Annu Rev Biophys Biomol Struct 32:399–424

    Article  CAS  Google Scholar 

  60. MacCoss MJ (2005) Curr Opin Chem Biol 9:88–94

    Article  CAS  Google Scholar 

  61. Chen EI, Hewel J, Felding-Habermann B, Yates JR 3rd (2006) Mol Cell Proteomics 5:53–56

    Article  CAS  Google Scholar 

  62. Loo JA (2003) Adv Protein Chem 65:25–56

    CAS  Article  Google Scholar 

  63. Loo JA, DeJohn DE, Du P, Stevenson TI, Ogorzalek Loo RR (1999) Med Res Rev 19:307–319

    Article  CAS  Google Scholar 

  64. Thevis M, Loo JA, Ogorzalek Loo RR, Schänzer W (2007) Rapid Commun Mass Spectrom 21:297–304

    Article  CAS  Google Scholar 

  65. Rivier L (2003) Anal Chim Acta 492:69–82

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank the Manfred-Donike Institute for Doping Analysis for supporting the presented work.

Author information

Affiliations

  1. Center for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Carl-Diem-Weg 6, 50933, Cologne, Germany

    Mario Thevis & Wilhelm Schänzer

Authors
  1. Mario Thevis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wilhelm Schänzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Thevis.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Thevis, M., Schänzer, W. Current role of LC–MS(/MS) in doping control. Anal Bioanal Chem 388, 1351–1358 (2007). https://doi.org/10.1007/s00216-007-1131-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-007-1131-4

Keywords

  • Doping
  • Sport
  • Mass spectrometry
  • Criteria
  • Peptide
  • Protein